Sage Therapeutics Inc. (SAGE) – it’s time to buy. Check out key Indicators

Stocks of Sage Therapeutics Inc. (NASDAQ:SAGE) traded higher last session on Wall Street, up 13.01% to $18.93. According to the data, Sage Therapeutics Inc. (NASDAQ:SAGE) has 21 analysts covering its stock. The consensus rating among analysts is ‘Hold’. As we calculate the median target price by taking the range between a high of $79.00 and […]

Reasons why Sage Therapeutics Inc.’s (NASDAQ:SAGE) fundamentals are futile

In yesterday’s Wall Street session, Sage Therapeutics Inc. (NASDAQ:SAGE) shares traded at $36.21, down -13.47% from the previous session. 21 analysts cover Sage Therapeutics Inc. (NASDAQ:SAGE), according to research data. The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $105.00 and a […]